TEVA PHARMACEUTICAL INDUSTRIES LIMITED OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax of -$2.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-12.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax · last filed 2018-02-12
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2017-12-31 was -$17.00M, a 168.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2017-09-30 was -$17.00M, a 122.67% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2017-06-30 was -$23.00M, a 135.38% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2017-03-31 was $55.00M, a 72.64% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2017 was -$2.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2016 was -$316.00M, a 197.53% decline from fiscal 2015.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2015 was $324.00M.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 3 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 6 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 9 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 9 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 12 month |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | -$17.00M derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | -$34.00M derived: sum of 2 quarters · filed 2018-02-12 | -$57.00M derived: sum of 3 quarters · filed 2018-02-12 | -$2.00M 10-K · filed 2018-02-12 | |||
| 2017-09-30 | -$17.00M derived: 6-K 9 month − 6-K 6 month · filed 2017-11-02 | -$40.00M derived: sum of 2 quarters · filed 2017-11-02 | $15.00M 6-K · filed 2017-11-02 | $40.00M derived: sum of 4 quarters · filed 2018-02-12 | |||
| 2017-06-30 | -$23.00M derived: 6-K 6 month − 6-K 3 month · filed 2017-08-03 | $32.00M 6-K · filed 2017-08-03 | $57.00M derived: sum of 3 quarters · filed 2018-02-12 | $132.00M derived: sum of 4 quarters · filed 2018-02-12 | |||
| 2017-03-31 | $55.00M 6-K · filed 2017-05-11 | $80.00M derived: sum of 2 quarters · filed 2018-02-12 | $155.00M derived: sum of 3 quarters · filed 2018-02-12 | $220.00M derived: sum of 4 quarters · filed 2018-02-12 | |||
| 2016-12-31 | $25.00M derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | $100.00M derived: sum of 2 quarters · filed 2018-02-12 | $165.00M derived: sum of 3 quarters · filed 2018-02-12 | -$316.00M 10-K · filed 2018-02-12 | |||
| 2016-09-30 | $75.00M 6-K · filed 2016-11-15 | $140.00M derived: sum of 2 quarters · filed 2016-11-15 | -$341.00M 6-K · filed 2017-11-02 | $341.00M 6-K · filed 2016-11-15 | $663.00M derived: sum of 4 quarters · filed 2018-02-12 | ||
| 2016-06-30 | $65.00M 6-K · filed 2016-08-04 | -$266.00M 6-K · filed 2017-08-03 | $266.00M 6-K · filed 2016-08-04 | $588.00M derived: sum of 3 quarters · filed 2018-02-12 | $622.00M derived: sum of 4 quarters · filed 2018-02-12 | ||
| 2016-03-31 | $201.00M 6-K · filed 2016-05-09 | $523.00M derived: sum of 2 quarters · filed 2018-02-12 | $557.00M derived: sum of 3 quarters · filed 2018-02-12 | $535.00M derived: sum of 4 quarters · filed 2018-02-12 | |||
| 2015-12-31 | $322.00M derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | $356.00M derived: sum of 2 quarters · filed 2018-02-12 | $334.00M derived: sum of 3 quarters · filed 2018-02-12 | $324.00M 10-K · filed 2018-02-12 | |||
| 2015-09-30 | $34.00M 6-K · filed 2016-11-15 | -$34.00M 6-K · filed 2015-10-29 | $12.00M derived: sum of 2 quarters · filed 2016-11-15 | $2.00M 6-K · filed 2016-11-15 | -$2.00M 6-K · filed 2015-10-29 | $9.00M derived: sum of 4 quarters · filed 2017-02-15 | |
| 2015-06-30 | -$22.00M 6-K · filed 2016-08-04 | $22.00M 6-K · filed 2015-07-30 | -$32.00M 6-K · filed 2016-08-04 | $32.00M 6-K · filed 2015-07-30 | -$25.00M derived: sum of 3 quarters · filed 2017-02-15 | -$48.00M derived: sum of 4 quarters · filed 2017-02-15 | |
| 2015-03-31 | -$10.00M 6-K · filed 2016-05-09 | $10.00M 6-K · filed 2015-04-30 | -$3.00M derived: sum of 2 quarters · filed 2017-02-15 | -$26.00M derived: sum of 3 quarters · filed 2017-02-15 | -$41.00M derived: sum of 4 quarters · filed 2017-02-15 | ||
| 2014-12-31 | $7.00M derived: 20-F 12 month − 6-K 9 month · filed 2017-02-15 | -$16.00M derived: sum of 2 quarters · filed 2017-02-15 | -$31.00M derived: sum of 3 quarters · filed 2017-02-15 | -$10.00M 20-F · filed 2017-02-15 | |||
| 2014-09-30 | -$23.00M 6-K · filed 2015-10-29 | -$38.00M derived: sum of 2 quarters · filed 2015-10-29 | -$17.00M 6-K · filed 2015-10-29 | -$7.00M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-06-30 | -$15.00M 6-K · filed 2015-07-30 | $6.00M 6-K · filed 2015-07-30 | $16.00M derived: sum of 3 quarters · filed 2016-02-11 | $21.00M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-03-31 | $20.00M 6-K · filed 2015-04-30 | $31.00M derived: sum of 2 quarters · filed 2016-02-11 | $36.00M derived: sum of 3 quarters · filed 2016-02-11 | $25.00M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2013-12-31 | $11.00M derived: 20-F 12 month − 6-K 9 month · filed 2016-02-11 | $16.00M derived: sum of 2 quarters · filed 2016-02-11 | $5.00M derived: sum of 3 quarters · filed 2016-02-11 | $12.00M 20-F · filed 2016-02-11 | |||
| 2013-09-30 | $5.00M 6-K · filed 2014-10-30 | -$6.00M derived: sum of 2 quarters · filed 2014-10-30 | $1.00M 6-K · filed 2014-10-30 | ||||
| 2013-06-30 | -$11.00M 6-K · filed 2014-07-31 | -$5.00M 6-K · filed 2014-07-31 | |||||
| 2013-03-31 | $6.00M 6-K · filed 2014-05-02 |